Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. | Blood Adv | 2023 | 37695745 | PubTator, text mining | PubMed |
| Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations. | iScience | 2023 | 37694139 | PubTator, text mining | PubMed |
| A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer. | Cureus | 2023 | 37692610 | PubTator, text mining | PubMed |
| Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice. | Cancers (Basel) | 2023 | 37686621 | PubTator, text mining | PubMed |
| The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma. | Cancers (Basel) | 2023 | 37686584 | PubTator, text mining | PubMed |
| Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects. | Nat Commun | 2023 | 37684243 | PubTator, text mining | PubMed |
| Impact of endocrine disruptors on peripheral blood mononuclear cells in vitro: role of gender. | Arch Toxicol | 2023 | 37676302 | PubTator, text mining | PubMed |
| Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles. | Microbiol Spectr | 2023 | 37676005 | PubTator, text mining | PubMed |
| Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative review. | Ann Transl Med | 2023 | 37675321 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. | Front Immunol | 2023 | 37675100 | PubTator, text mining | PubMed |
| Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells. | iScience | 2023 | 37674985 | PubTator, text mining | PubMed |
| Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy. | Front Immunol | 2023 | 37671150 | PubTator, text mining | PubMed |
| A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy. | Cell Rep Methods | 2023 | 37671017 | PubTator, text mining | PubMed |
| Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection. | JCI Insight | 2023 | 37669115 | PubTator, text mining | PubMed |
| RAIDS atlas of significant genetic and protein biomarkers in cervical cancer. | J Gynecol Oncol | 2023 | 37668079 | PubTator, text mining | PubMed |
| Prognostic and predictive significance of GITR in metastatic renal cell carcinoma. | Eur Rev Med Pharmacol Sci | 2023 | 37667956 | PubTator, text mining | PubMed |
| Machine learning-based identification of glycosyltransferase-related mRNAs for improving outcomes and the anti-tumor therapeutic response of gliomas. | Front Pharmacol | 2023 | 37663248 | PubTator, text mining | PubMed |
| Identification of molecular subtypes and immune infiltration in endometriosis: a novel bioinformatics analysis and In vitro validation. | Front Immunol | 2023 | 37662927 | PubTator, text mining | PubMed |
| Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands. | Ther Adv Vaccines Immunother | 2023 | 37662491 | PubTator, text mining | PubMed |
| Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease. | EBioMedicine | 2023 | 37657135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=20